Advisory Services Network’s Acadia Pharmaceuticals ACAD Stock Holding History

Advisory Services Network’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.5K	Buy	+1,056	New	+$25.2K	﹤0.01%	3104
2024 Q1	–	Sell	-6	Closed	-$188	–	1461
2023 Q4	$188	Buy	+6	New	+$143	﹤0.01%	3738
2021 Q1	–	Sell	-25	Closed	-$1K	–	1286
2020 Q4	$1K	Buy	+25	New	+$1.24K	﹤0.01%	3099
2020 Q1	–	Sell	-1,648	Closed	-$71K	–	2994
2019 Q4	$71K	Buy	+1,648	New	+$71.7K	﹤0.01%	1323
2014 Q2	–	Sell	-10,715	Closed	-$261K	–	246
2014 Q1	$261K	Sell	10,715 -639	-6%	-$16.2K	0.13%	167
2013 Q4	$284K	Buy	+11,354	New	+$268K	0.14%	141

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Advisory Services Network's ACAD Position: Q1 2026 in Review

Advisory Services Network opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2026: 1,056 shares worth $23.5K. The stake represents ﹤0.01% of the portfolio and ranks #3104 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in ACAD as recently as Q4 2023.

Advisory Services Network first reported a position in ACAD in Q4 2013 and has held it in 6 quarters since. The position peaked at $284K in Q4 2013. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Advisory Services Network held 1,056 shares of Acadia Pharmaceuticals worth $23.5K as of Q1 2026.
Acadia Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3104 holding.
Advisory Services Network first reported a position in Acadia Pharmaceuticals in Q4 2013 and has held it in 6 quarters since.
Advisory Services Network's Acadia Pharmaceuticals position peaked at $284K in Q4 2013.
340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.